BeOne Medicines Ltd ADR
BeOne Medicines Ltd ADR (ONC) Implied Volatility Current
ONC implied volatility is 33%. IV Rank is 1%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking ONC implied volatility helps you identify when options premiums on BeOne Medicines Ltd ADR are historically cheap or expensive, and where the best trades are hiding. BeOne Medicines Ltd ADR implied volatility reflects the market's expectation of future price movement: when ONC IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor BeOne Medicines Ltd ADR's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ONC, tracking metrics like ONC IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ONC signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies. Founded in 2010 and headquartered in Cambridge, Massachusetts—with operations spanning over 45 countries across six continents—the company rebranded as BeOne in late 2024 and redomiciled to Basel, Switzerland in 2025. BeOne has established itself as a leader in immuno-oncology and targeted therapies, with key assets including Tevimbra (tislelizumab), a PD-1 monoclonal antibody approved for multiple cancer indications globally, and Brukinsa (zanubrutinib), a Bruton's tyrosine kinase (BTK) inhibitor that surpassed $1.3 billion in annual sales and is approved in major markets such as the U.S., Europe, and China.
The company’s strategy combines internal R&D with the development of assets sourced from external partnerships, driving a robust pipeline across hematologic malignancies and solid tumors.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ONC implied volatility sits today versus where it has been. Our scanner ranks BeOne Medicines Ltd ADR implied volatility against its historical range, surfaces extremes in ONC IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether BeOne Medicines Ltd ADR IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 18, 2026
Trade options with IV on your side
Track ONC IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→